2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
Détails
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_EFBB910B02B7
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
Périodique
Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo
Collaborateur⸱rice⸱s
Panel Members
Contributeur⸱rice⸱s
Stahel R., Felip E., Peters S., Kerr K., Besse B., Vansteenkiste J., Eberhardt W., Edelman M., Mok T., O'Byrne K., Novello S., Bubendorf L., Marchetti A., Baas P., Reck M., Syrigos K., Paz-Ares L., Smit EF., Meldgaard P., Adjei A., Nicolson M., Crinó L., Van Schil P., Senan S., Faivre-Finn C., Rocco G., Veronesi G., Douillard JY., Lim E., Dooms C., Weder W., De Ruysscher D., Le Pechoux C., De Leyn P., Westeel V.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
26
Numéro
8
Pages
1573-1588
Langue
anglais
Notes
Publication types: Consensus Development Conference ; Journal Article ; Practice Guideline ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.
Mots-clé
Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bronchoscopy, Carboplatin/administration & dosage, Carcinoma, Non-Small-Cell Lung/diagnosis, Carcinoma, Non-Small-Cell Lung/pathology, Chemotherapy, Adjuvant, Cisplatin/administration & dosage, Disease Management, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Etoposide/administration & dosage, Europe, Humans, Lung/pathology, Lung/radiography, Lung Neoplasms/diagnosis, Lung Neoplasms/pathology, Lymph Nodes/pathology, Mediastinum, Multimodal Imaging, Pneumonectomy, Positron-Emission Tomography, Radiotherapy, Adjuvant, Societies, Medical, Tomography, X-Ray Computed, Vinblastine/administration & dosage, Vinblastine/analogs & derivatives
Pubmed
Web of science
Open Access
Oui
Création de la notice
07/09/2015 15:47
Dernière modification de la notice
14/02/2022 8:57
Données d'usage
